Searched for
LENNOX GASTAUT SYNDROME
Alembic Pharma gets USFDA nod for generic drugAlembic Pharmaceuticals has secured approval from the US health regulator for a generic seizure medication. The company received final clea...- UK boy gets world's first epilepsy device inserted into skull. Know in detail about neurostimulators fitted into brainA 13-year-old kid, Oran Knowlson from Somerset is the first to test a neurostimulator device for severe epilepsy. Three more Lennox-Gastaut...
- World's first epilepsy device fitted in 13 year old UK boy's skull; Here's how the device worksOran Knowlson, a 13-year-old from England with severe epilepsy, has become the first person to trial a new device implanted in his skull to...
- Akumentis Healthcare launches drug for treatment of epilepsy"We understand the immense physical and emotional toll that frequent seizures can have on patients and their families," Akumentis Executive...
- Focus shifts to healthcare delivery in 2023 as Covid stress easesA major initiative this year has been the launch of the National Sickle Cell Anaemia Elimination Mission by Prime Minister Narendra Modi in...
- Medicines for four rare diseases become cheaper due to domestic productionDrugs for four of these diseases -Tyrosinemia Type 1, Gaucher's Disease, Wilson's Disease and Dravet-Lennox Gastaut Syndrome - along with s...
- Glenmark Pharma launches anti-epileptic drug, Rufinamide, in the USThe newly launched drug is a therapeutic equivalent of Banzel tablets, 200 mg and 400 mg of Eisai, Inc. Banzel tablets are used in combinat...
- Alembic Pharma gets USFDA nod for seizure treatment drugThe approved product is therapeutically equivalent to the reference listed drug Klonopin orally disintegrating tablets of Hoffmann-La Roche...
- Lupin launches generic seizure drug in USThe company has launched Clobazam tablets in the strengths of 10 mg and 20 mg, after having received an approval from the United States Foo...
- Stocks in the news: HDFC, Lupin, JMC Projects, Axis Bank and Indiabulls Real EstateHere are a few stocks which may buzz the most in today’s session.
- Glenmark gets final nod by USFDA to sell Rufinamide drugRufinamide is used to treat seizures caused by Lennox-Gastaut syndrome, it will be available as tablets in 200 mg and 400 mg strengths.
- Glenmark gets tentative USFDA nod to sell RufinamideGlenmark Pharmaceuticals today said it has been granted tentative approval by the US health regulator to sell Rufinamide.
Load More
